Get started
StockGuild

$BVXV Overreaction to Phase 3 Trial Anticipating $20 PT

Long
StockGuild  
NASDAQ:BVXV   None
Support and Resistance Fibonacci Wedge BVXV breakout NEWS fda trialstudies techs overreaction nasdaq BTC
3
0
supportandresistance fibonacci wedgepattern bvxv breakout news fda trialstudies techs overreaction nasdaq btc
Dropped from $40 to $3 on Phase 3 trial failure wasn’t even an FDA denial. Has facilities and will be focusing on other trials. Total overreaction. PT $20+

The study’s primary safety endpoint was also met.

Related Ideas

StockGuild
$BVXV 15 Min Wedge Wave Cycle Accelerating Breakout by 2:30
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.